• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Seaport Calibre Materials Acquisition Corp.

    2/2/23 4:15:02 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous
    Get the next $SCMA alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-40975
    Issuer: Seaport Calibre Materials Acquisition Corp.
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 360 Madison Avenue
    New York NEW YORK 10017
    Telephone number: 212-616-7700
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Class A Common Stock, Warrant, Unit
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2023-02-02 By Tara Petta AVP
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SCMA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SCMA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SCMA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Seaport Calibre Materials Acquisition Corp. Announces It Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination

    NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Seaport Calibre Materials Acquisition Corp. (NASDAQ:SCMA) (the "Company") announced today that, because the Company will not consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation (the "Amended Charter"), the Company intends to dissolve and liquidate in accordance with the provisions of the Amended Charter, effective as of the close of business on February 1, 2023. On January 13, 2023, the Company filed with the Securities and Exchange Commission a definitive proxy statement (the "Proxy Statement") in connection with a special meeting of stockholders to consider and vot

    2/1/23 9:00:00 AM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    Seaport Calibre Materials Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders

    NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Seaport Calibre Materials Acquisition Corp. (Nasdaq: SCMA) (the "Company") announced today that it has postponed the Company's Special Meeting of Stockholders to be held on January 26, 2023, until January 31, 2023, at 1:00 p.m. Eastern Time. The postponed Special Meeting will be completely virtual and stockholders will be able to attend the special meeting online, vote and submit questions by visiting https://www.cstproxy.com/seaportcalibreacquisition/2023. There will be no change in the record date as a result of this postponement, and proxies tendered prior to the postponed date will not need to be voted again. Stockholders may elect to redeem

    1/26/23 5:00:00 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    $SCMA
    SEC Filings

    View All

    SEC Form 15-12G filed by Seaport Calibre Materials Acquisition Corp.

    15-12G - Seaport Calibre Materials Acquisition Corp. (0001863428) (Filer)

    2/13/23 4:33:20 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    SEC Form 25-NSE filed by Seaport Calibre Materials Acquisition Corp.

    25-NSE - Seaport Calibre Materials Acquisition Corp. (0001863428) (Subject)

    2/2/23 4:15:02 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    Seaport Calibre Materials Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Seaport Calibre Materials Acquisition Corp. (0001863428) (Filer)

    2/1/23 9:10:38 AM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    $SCMA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Barclays Plc

    4 - Seaport Calibre Materials Acquisition Corp. (0001863428) (Issuer)

    8/26/22 1:50:25 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    SEC Form 3: New insider Barclays Plc claimed ownership of 1,481,560 shares

    3 - Seaport Calibre Materials Acquisition Corp. (0001863428) (Issuer)

    8/26/22 10:39:08 AM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    $SCMA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Seaport Calibre Materials Acquisition Corp. (Amendment)

    SC 13G/A - Seaport Calibre Materials Acquisition Corp. (0001863428) (Subject)

    2/14/24 1:28:06 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    SEC Form SC 13G/A filed by Seaport Calibre Materials Acquisition Corp. (Amendment)

    SC 13G/A - Seaport Calibre Materials Acquisition Corp. (0001863428) (Subject)

    2/9/24 11:04:13 AM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous

    SEC Form SC 13G/A filed by Seaport Calibre Materials Acquisition Corp. (Amendment)

    SC 13G/A - Seaport Calibre Materials Acquisition Corp. (0001863428) (Subject)

    2/14/23 3:30:17 PM ET
    $SCMA
    Other Pharmaceuticals
    Miscellaneous